News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Philip A. Poole-Wilson, MD

Articles by Philip A. Poole-Wilson, MD

High-Versus Low-dose Angiotensin Converting Enzyme Inhibitor Therapy in the Treatment of Heart Failure: An Economic Analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial

ByJ. Sanford Schwartz, MD,Y. Richard Wang, MD, PhD,John G. F. Cleland, MD,Longlong Gao, MS,Mark Weiner, MD,Philip A. Poole-Wilson, MD,fo

June 1st 2003

Latest Updated Articles

High-Versus Low-dose Angiotensin Converting Enzyme Inhibitor Therapy in the Treatment of Heart Failure: An Economic Analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial
Published: June 1st 2003 | Updated:

Trending on AJMC

Cefdinir Nearly Doubles Outpatient Uncomplicated UTI Treatment Failure Compared With Cephalexin

Stronger Carer-Child Bonds Don’t Predict Later Mental Health

Five Ways AI Is Transforming Cancer Care—and Companies That Are Making It Happen

FDA to Remove Black Box Warnings From HRT, Debate Ensues

Intermountain Spans Time Zones, Cultures to Bring Oncology Care to Alaska

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.